Multifaced Roles of the αvβ3 Integrin in Ehlers–Danlos and Arterial Tortuosity Syndromes’ Dermal Fibroblasts
Open accessAbstract
The αvβ3 integrin, an endothelial cells’ receptor-binding fibronectin (FN) in the extracellular matrix (ECM) of blood vessels, regulates ECM remodeling during migration, invasion, angiogenesis, wound healing and inflammation, and is also involved in the epithelial mesenchymal transition. In vitro-grown human control fibroblasts organize a fibrillar network of FN, which is preferentially bound on the entire cell surface to its canonical α5β1 integrin receptor, whereas the αvβ3 integrin is present only in rare patches in focal contacts. We report on the preferential recruitment of the αvβ3 integrin, due to the lack of FN–ECM and its canonical integrin receptor, in dermal fibroblasts from Ehlers–Danlos syndromes (EDS) and arterial tortuosity syndrome (ATS), which are rare multisystem connective tissue disorders. We review our previous findings that unraveled different biological mechanisms elicited by the αvβ3 integrin in fibroblasts derived from patients affected with classical (cEDS), vascular (vEDS), hypermobile EDS (hEDS), hypermobility spectrum disorders (HSD), and ATS. In cEDS and vEDS, respectively, due to defective type V and type III collagens, αvβ3 rescues patients’ fibroblasts from anoikis through a paxillin-p60Src-mediated cross-talk with the EGF receptor. In hEDS and HSD, without a defined molecular basis, the αvβ3 integrin transduces to the ILK-Snail1-axis inducing a fibroblast-to-myofibroblast-transition. In ATS cells, the deficiency of the dehydroascorbic acid transporter GLUT10 leads to redox imbalance, ECM disarray together with the activation of a non-canonical αvβ3 integrin-TGFBRII signaling, involving p125FAK/p60Src/p38MAPK. The characterization of these different biological functions triggered by αvβ3 provides insights into the multifaced nature of this integrin, at least in cultured dermal fibroblasts, offering future perspectives for research in this field.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
cEDS cells exhibit reduced in vitro migration capability.
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
cEDS cells exhibit an abnormal wound healing response.
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
cEDS cells exhibit a crosstalk involving the αvβ3 integrin and EGF receptor that rescues them from anoikis.
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
Matrix perturbation may act as a key driving factor for EDS pathogenesis irrespective of underlying molecular defects.
“This ECM signature is in common with cEDS and vEDS cells, underlining that the matrix perturbation may act as a key driving factor for the EDS pathogenesis, irrespective of the underlying molecular defects [50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
vEDS fibroblasts show differential expression of several genes encoding structural constituents of the ECM.
“In line with cEDS and hEDS transcriptome profiling, vEDS fibroblasts show the differential expression of several genes encoding structural constituents of the ECM, further supporting the notion that abnormal ECM remodeling is a common denominator of these conditions [50,97].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
Aberrant expression of collagen V and defective remodeling of ECM in cEDS cells might affect ER homeostasis and autophagy, and consequently activate a pro-survival mechanism mediated by a crosstalk between αvβ3 integrin and EGF receptor.
“In line with these observations, the aberrant expression of collagen V and defective remodeling of ECM in cEDS cells might affect ER homeostasis and autophagy, and consequently activate a pro-survival mechanism mediated by a crosstalk between αvβ3 integrin and EGF receptor [45,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
Abnormal ECM remodeling is a common denominator of cEDS, vEDS, and hEDS.
“In line with cEDS and hEDS transcriptome profiling, vEDS fibroblasts show the differential expression of several genes encoding structural constituents of the ECM, further supporting the notion that abnormal ECM remodeling is a common denominator of these conditions [50,97].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
hEDS/HSD, cEDS, and vEDS fibroblasts exhibit marked disorganization of collagen and fibronectin ECM and their specific α2β1 and α5β1 integrin receptors and show preferential expression of the αvβ3 integrin.
“In particular, hEDS/HSD, cEDS, and vEDS fibroblasts exhibit a marked disorganization of collagen and fibronectin ECM and their specific α2β1 and α5β1 integrin receptors and showed the preferential expression of the αvβ3 integrin [44,49,50,123].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
vEDS fibroblasts are in a pre-apoptotic state due to downregulation of the Bcl-2 anti-apoptotic protein and increased levels of caspase enzymes, and activate a cell survival mechanism through an αvβ3-EGFR crosstalk.
“Consistently, we previously demonstrated that vEDS fibroblasts are in a pre-apoptotic state, due to downregulation of the Bcl-2 anti-apoptotic protein and increased levels of caspase enzymes, and activate a cell survival mechanism through an αvβ3-EGFR crosstalk [45,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
This ECM signature is in common with cEDS and vEDS cells.
“This ECM signature is in common with cEDS and vEDS cells, underlining that the matrix perturbation may act as a key driving factor for the EDS pathogenesis, irrespective of the underlying molecular defects [50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
This phenotypic switch is elicited by a signal transduction pathway involving αvβ3 integrin signaling through ILK and transcription factor Snail1.
“This phenotypic switch is elicited by a signal transduction pathway involving the αvβ3 integrin that signals through the integrin linked kinase (ILK) and the transcription factor Snail1 [49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
ILK acts downstream of phosphatidylinositol 3-kinase signaling and negatively regulates GSK3β by phosphorylation of a specific serine residue.
“The ILK acts downstream of the phosphatidylinositol 3-kinase signaling pathway and negatively regulates the action of the glycogen synthase kinase 3β by phosphorylation of a specific serine residue, further strengthening our assumption that Wnt/β-catenin signaling is involved in hEDS/HSD pathogenesis [49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269 · see citing works
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323 · see citing works
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575 · see citing works
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · see citing works
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334 · see citing works
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869 · see citing works
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · see citing works
The Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527 · see citing works
Structure and function of matrix metalloproteinases and TIMPs
Nagase, H., Visse, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,416 · see citing works
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.619 · Cited by 3,272 · see citing works
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024 · see citing works
Requirement of Vascular Integrin α <sub>v</sub> β <sub>3</sub> for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020 · see citing works
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598 · see citing works
Role of cell shape in growth control
Folkman, J., & Moscona, A. (1978) · Nature · doi:10.1038/273345a0 · Cited by 2,422 · see citing works
Mediators of endoplasmic reticulum stress-induced apoptosis
Szegezdi, E., Logue, S. E., Gorman, A. M., & Samali, A. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400779 · Cited by 2,345 · see citing works
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262 · see citing works
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,014 · see citing works
Pankov, R. G., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 1,956 · see citing works
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · cited 4× · see citing works
“Briefly, cEDS is characterized by abnormal skin involvement and generalized JHM (gJHM) [90,91], and is mainly caused by mutations in the COL5A1 and COL5A2 genes encoding the type V collagen (COLLV) [92,93].”
BackgroundInfluentialSelf-citationThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · see citing works
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · see citing works
The extracellular matrix as a cell survival factor.
Meredith, J. E., Fazeli, B., & Schwartz, M. A. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.9.953 · Cited by 1,540 · see citing works
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,473 · see citing works
The extracellular matrix in development and morphogenesis: A dynamic view
Rozario, T., & DeSimone, D. W. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.10.026 · Cited by 1,449 · see citing works
Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
Hynes, R. O., & Naba, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004903 · Cited by 1,349 · see citing works
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
Pepin, M., Schwarze, U., Superti-Furga, A., & Byers, P. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421001 · Cited by 1,344 · see citing works
Daynes, R. A., Araneo, B. A., Ershler, W. B., Maloney, C., Li, G. Z., & Ryu, S. Y. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5219 · Cited by 1,264 · see citing works
Talin Binding to Integrin ß Tails: A Final Common Step in Integrin Activation
Tadokoro, S., Shattil, S. J., Eto, K., Tai, V., Liddington, R., de Pereda, J. M., Ginsberg, M. H., & Calderwood, D. (2003) · Science · doi:10.1126/science.1086652 · Cited by 1,211 · see citing works
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193 · see citing works
Integrin Structure, Activation, and InteractionsPreprint
Campbell, I. D., & Humphries, M. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004994 · Cited by 1,192 · see citing works
Interaction of plasma membrane fibronectin receptor with talin—a transmembrane linkage
Horwitz, A. F., Duggan, K., Buck, C. A., Beckerle, M. C., & Burridge, K. (1986) · Nature · doi:10.1038/320531a0 · Cited by 1,191 · see citing works
Edwards, D. R., Handsley, M. M., & Pennington, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,165 · see citing works
Frisch, S. M., & Ruoslahti, E. I. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80124-x · Cited by 1,153 · see citing works
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.19.11211 · Cited by 1,149 · see citing works
Proteases: Multifunctional Enzymes in Life and Disease
López-Otı́n, C., & Bond, J. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800035200 · Cited by 1,146 · see citing works
Molecular complexity and dynamics of cell-matrix adhesions
Zamir, E., & Geiger, B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.20.3583 · Cited by 1,110 · see citing works
Integrin-mediated mechanotransduction
Sun, Z., Guo, S., & Fässler, R. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201609037 · Cited by 1,079 · see citing works
Human and mouse proteases: a comparative genomic approach
Puente, X. S., Sánchez, L. M., Overall, C. M., & López-Otı́n, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1111 · Cited by 940 · see citing works
The impact of the extracellular matrix on inflammation
Sorokin, L. M. (2010) · Nature reviews. Immunology · doi:10.1038/nri2852 · Cited by 911 · see citing works
Cell interactions with three-dimensional matrices
Cukierman, E., Pankov, R. G., & Yamada, K. M. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00364-2 · Cited by 889 · see citing works
Serini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847 · see citing works
Marini, J. C., Forlino, A., Bächinger, H. P., Bishop, N. J., Byers, P. H., Paepe, A. D., Fassier, F., Fratzl-Zelman, N., Kozloff, K. M., Krakow, D., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.52 · Cited by 842 · see citing works
Paxillin and focal adhesion signalling
Turner, C. E. (2000) · Nature Cell Biology · doi:10.1038/35046659 · Cited by 839 · see citing works
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R. L., Visscher, D. W., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828 · see citing works
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 817 · see citing works
TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
Wu, Y., & Zhou, B. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605530 · Cited by 801 · see citing works
Networks and crosstalk: integrin signalling spreads
Schwartz, M. A., & Ginsberg, M. H. (2002) · Nature Cell Biology · doi:10.1038/ncb0402-e65 · Cited by 797 · see citing works
Integrins in Cell MigrationPreprint
Anna Huttenlocher, A., & Horwitz, A. R. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005074 · Cited by 762 · see citing works
The Tail of Integrins, Talin, and Kindlins
Moser, M., Legate, K. R., Zent, R., & Fässler, R. (2009) · Science · doi:10.1126/science.1163865 · Cited by 752 · see citing works
Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment
van Dijk, F. V., & Sillence, D. (2014) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.36545 · Cited by 734 · see citing works
The Adaptor Protein Shc Couples a Class of Integrins to the Control of Cell Cycle Progression
Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., & Giancotti, F. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81392-6 · Cited by 731 · see citing works
Integrins and Extracellular Matrix in Mechanotransduction
Schwartz, M. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005066 · Cited by 662 · see citing works
Kornblihtt, A. R., Umezawa, K., Vibe‐Pedersen, K., & Baralle, F. E. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03847.x · Cited by 659 · see citing works
Host Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2012) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624 · see citing works
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Xu, W., Yang, Z., & Lü, N. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1016686 · Cited by 611 · see citing works
A framework for the classification of joint hypermobility and related conditions
Castori, M., Tinkle, B., Levy, H., Grahame, R., Malfait, F., & Hakim, A. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31539 · Cited by 602 · cited 1× · see citing works
“Following the new classification, the term hypermobility spectrum disorders (HSD) is an alternative label for patients with symptomatic JHM who do not meet the new criteria for hEDS [97].”
BackgroundBrown, M. C., & Turner, C. E. (2004) · Physiological Reviews · doi:10.1152/physrev.00002.2004 · Cited by 601 · see citing works
Integrin-linked kinase: a cancer therapeutic target unique among its ILK
Hannigan, G. E., Troussard, A. A., & Dedhar, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1524 · Cited by 589 · see citing works
Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G., & Defilippi, P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6622 · Cited by 585 · see citing works
Dynamics and segregation of cell–matrix adhesions in cultured fibroblasts
Zamir, E., Katz, M., Posen, Y., Noam Erez, A., Yamada, K. M., Katz, B., Lin, S., Lin, D. C., Bershadsky, A. D., Kam, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35008607 · Cited by 582 · see citing works
Get a ligand, get a life: integrins, signaling and cell survival
Stupack, D. G., & Cheresh, D. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.00071 · Cited by 580 · see citing works
Molecular Architecture and Function of Matrix AdhesionsPreprint
Geiger, B., & Yamada, K. M. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005033 · Cited by 548 · see citing works
Paxillin: a focal adhesion-associated adaptor protein
Schaller, M. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204786 · Cited by 542 · see citing works
Hierarchical assembly of cell–matrix adhesion complexes
Zaidel‐Bar, R., Cohen, M. D., Addadi, L., & Geiger, B. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320416 · Cited by 523 · see citing works
Re, F., Zanetti, A., Sironi, M., Polentarutti, N., Lanfrancone, L., Dejana, E., & Colotta, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.2.537 · Cited by 499 · see citing works
Tinkle, B., Castori, M., Berglund, B., Cohen, H., Grahame, R., Kazkaz, H., & Levy, H. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31538 · Cited by 499 · see citing works
Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.
ffrench‐Constant, C., Water, L. V. D., Dvorak, H. F., & Hynes, R. O. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.2.903 · Cited by 482 · see citing works
Integrin Dynamics and Matrix Assembly
Pankov, R., Cukierman, E., Katz, B.-Z., Matsumoto, K., Lin, D. C., Lin, S., Hahn, C., & Yamada, K. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.1075 · Cited by 482 · see citing works
Babic, A. M., Chen, C.-C., & Lau, L. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2958 · Cited by 445 · see citing works
Exploring the Role of RGD-Recognizing Integrins in Cancer
Nieberler, M., Reuning, U., Reichart, F., Notni, J., Wester, H., Schwaiger, M., Weinmüller, M., Räder, A. F. B., Steiger, K., & Kessler, H. (2017) · Cancers · doi:10.3390/cancers9090116 · Cited by 429 · see citing works
Hinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424 · see citing works
Coucke, P. J., Willaert, A., Wessels, M. W., Callewaert, B. L., Zoppi, N., Backer, J. F. A. D., Fox, J. E., Mancini, G. M. S., Kambouris, M., Gardella, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1764 · Cited by 399 · see citing works
Self-citationCell-Extracellular Matrix Interactions in Normal and Diseased Skin
Watt, F. M., & Fujiwara, H. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005124 · Cited by 384 · see citing works
Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C., & Cheresh, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118808 · Cited by 382 · see citing works
Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome
Byers, P. H., Belmont, J., Black, J., De Backer, J., Frank, M., Jeunemaitre, X., Johnson, D., Pepin, M., Robert, L., Sanders, L., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31553 · Cited by 381 · see citing works
Cross Talk among TGF- Signaling Pathways, Integrins, and the Extracellular Matrix
Munger, J. S., & Sheppard, D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005017 · Cited by 372 · see citing works
Kindlin-2 (Mig-2): a co-activator of β3 integrins
Ma, Y., Qin, J., Wu, C., & Plow, E. F. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710196 · Cited by 352 · see citing works
The αvβ3 integrin “vitronectin receptor”
Horton, M. A. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00155-0 · Cited by 349 · see citing works
CCN1/CYR61: the very model of a modern matricellular protein
Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338 · see citing works
Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations
Bateman, J. F., Boot-Handford, R. P., & Lamandé, S. R. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2520 · Cited by 338 · see citing works
Dave, N., Guaita‐Esteruelas, S., Gutarra, S., Frías, A., Beltran-Nebot, M., Peiró, S., & de Herreros, A. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168625 · Cited by 332 · see citing works
Anders, H., & Schaefer, L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010117 · Cited by 328 · see citing works
Plasma fibronectin is synthesized and secreted by hepatocytes.
Tamkun, J. W., & Hynes, R. O. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32672-3 · Cited by 319 · see citing works
Muro, A. F., Chauhan, A. K., Gajovic, S., Iaconcig, A., Porro, F., Stanta, G., & Baralle, F. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212079 · Cited by 319 · see citing works
Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome
Meester, J., Verstraeten, A., Schepers, D., Alaerts, M., Laer, L. V., & Loeys, B. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.11.03 · Cited by 309 · see citing works
Akt is more than just a Bad kinase
Khwaja, A. (1999) · Nature · doi:10.1038/43354 · Cited by 302 · see citing works
Integrin regulation of growth factor receptors
Yamada, K. M., & Even‐Ram, S. (2002) · Nature Cell Biology · doi:10.1038/ncb0402-e75 · Cited by 295 · see citing works
Integrins and tumor cell dissemination.
Ruoslahti, E. I., & Giancotti, F. G. (1989) · PubMed · Cited by 291 · see citing works
Rosin, D. L., & Okusa, M. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040430 · Cited by 284 · see citing works
Adhesion receptors of vascular smooth muscle cells and their functions
Moiseeva, E. P. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00399-6 · Cited by 282 · see citing works
Karsdal, M. A., Nielsen, M. J., Sand, J. M. B., Henriksen, K., Genovese, F., Bay‐Jensen, A., Smith, V., Adamkewicz, J. I., Christiansen, C., & Leeming, D. J. (2012) · Assay and Drug Development Technologies · doi:10.1089/adt.2012.474 · Cited by 281 · see citing works
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
Kim, H. E., Dalal, S. S., Young, E. F., Legato, M. J., Weisfeldt, M. L., & D'Armiento, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8040 · Cited by 281 · see citing works
A Signaling Pathway from the α5β1 and αvβ3 Integrins That Elevatesbcl-2 Transcription
Matter, M. L., & Ruoslahti, E. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102014200 · Cited by 244 · see citing works
Schellenberg, B., Wang, P., Keeble, J. A., Rodriguez-Enriquez, R., Walker, S., Owens, T. W., Foster, F., Tanianis-Hughes, J., Brennan, K., Streuli, C. H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.12.022 · Cited by 237 · see citing works
Galliher, A. J., & Schiemann, W. P. (2006) · Breast Cancer Research · doi:10.1186/bcr1524 · Cited by 236 · see citing works
Fibronectin EDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
Bhattacharyya, S., Tamaki, Z., Wang, W., Hinchcliff, M., Hoover, P., Getsios, S., White, E. S., & Varga, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008264 · Cited by 234 · see citing works
Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y., & Tamaki, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7708 · Cited by 231 · see citing works
Extracellular matrix signaling in morphogenesis and repair
Clause, K. C., & Barker, T. H. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.04.011 · Cited by 230 · see citing works
Kornblihtt, A. R., Vibe‐Pedersen, K., & Baralle, F. E. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.14.5853 · Cited by 219 · see citing works
Nikolopoulos, S. N., & Turner, C. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102163200 · Cited by 213 · see citing works
Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction
Sarrazy, V., Koehler, A., Chow, M. L., Zimina, E., Li, C. X., Kato, H., Caldarone, C. A., & Hinz, B. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu053 · Cited by 209 · see citing works
Alternative Splicing of Fibronectin—Many Different Proteins but Few Different Functions
ffrench‐Constant, C. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1374 · Cited by 208 · see citing works
The fibronectin gene as a model for splicing and transcription studies
Kornblihtt, A. R., Pesce, C. G., Alonso, C. R., Cramer, P., Srebrow, A., Werbajh, S., & Muro, A. F. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.2.8641558 · Cited by 203 · see citing works
Integrin Bidirectional Signaling: A Molecular View
Qin, J., Vinogradova, O., & Plow, E. F. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020169 · Cited by 189 · see citing works
Fibroblasts as novel therapeutic targets in chronic inflammation
Flavell, S. J., Hou, T. Z., Lax, S., Filer, A. D., Salmon, M., & Buckley, C. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707487 · Cited by 186 · see citing works
Ehlers-Danlos syndrome, classical type
Bowen, J. M., Sobey, G. J., Burrows, N. P., Colombi, M., Lavallee, M. E., Malfait, F., & Francomano, C. A. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31548 · Cited by 184 · see citing works
Self-citationBannerman, D. D., Sathyamoorthy, M., & Goldblum, S. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35371 · Cited by 183 · see citing works
Błyszczuk, P., Müller‐Edenborn, B., Valenta, T., Osto, E., Stellato, M., Behnke, S., Glatz, K., Basler, K., Lüscher, T. F., Distler, O., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw116 · Cited by 182 · see citing works
The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.
Bondeson, J., Wainwright, S., Hughes, C., & Caterson, B. (2008) · PubMed · Cited by 181 · see citing works
Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease
Gjaltema, R. A. F., & Bank, R. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1269716 · Cited by 175 · see citing works
The integrin αVβ6 binds and activates latent TGFβ3
Annes, J. P., Rifkin, D. B., & Munger, J. S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03280-x · Cited by 173 · see citing works
Carthy, J. M., Garmaroudi, F. S., Luo, Z., & McManus, B. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019809 · Cited by 172 · see citing works
Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells.
Norton, P. A., & Hynes, R. O. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.12.4297 · Cited by 171 · see citing works
Symoens, S., Syx, D., Malfait, F., Callewaert, B., De Backer, J., Vanakker, O., Coucke, P., & De Paepe, A. (2012) · Human Mutation · doi:10.1002/humu.22137 · Cited by 165 · see citing works
Baumann, M., Giunta, C., Krabichler, B., Rüschendorf, F., Zoppi, N., Colombi, M., Bittner, R. E., Quijano-Roy, S., Muntoni, F., Cirak, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.004 · Cited by 162 · see citing works
Self-citationCastori, M., Morlino, S., Celletti, C., Ghibellini, G., Bruschini, M., Grammatico, P., Blundo, C., & Camerota, F. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36315 · Cited by 159 · see citing works
Kasperkovitz, P. V., Timmer, T. C. G., Smeets, T. J., Verbeet, N. L., Tak, P. P., van baarsen, L. G. M., Baltus, B., Huizinga, T. W. J., Pieterman, E., Fero, M., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20811 · Cited by 148 · see citing works
αv integrins: key regulators of tissue fibrosis
Conroy, K. P., Kitto, L. J., & Henderson, N. C. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2407-9 · Cited by 146 · see citing works
Control of Cell Cycle Progression by Fibronectin Matrix Architecture
Sechler, J. L., & Schwarzbauer, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25533 · Cited by 142 · see citing works
Lee, Y., Huang, H.-Y., Chang, C.-J., Cheng, C.-H., & Chen, Y. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq286 · Cited by 137 · see citing works
Rosen, K. V., Rak, J. W., Leung, T., Dean, N. M., Kerbel, R. S., & Filmus, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.447 · Cited by 135 · see citing works
Burkitt Wright, E. M. M., Spencer, H. L., Daly, S. B., Manson, F. D. C., Zeef, L. A. H., Urquhart, J., Zoppi, N., Bonshek, R., Tosounidis, I., Mohan, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.007 · Cited by 135 · see citing works
Self-citationRitelli, M., Dordoni, C., Venturini, M., Chiarelli, N., Quinzani, S., Traversa, M., Zoppi, N., Vascellaro, A., Wischmeijer, A., Manfredini, E., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-58 · Cited by 134 · see citing works
Self-citationIdentification of a third region of cell-specific alternative splicing in human fibronectin mRNA.
Gutman, A., & Kornblihtt, A. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7179 · Cited by 132 · see citing works
The role of β3-integrins in tumor angiogenesis: context is everything
Robinson, S. D., & Hodivala‐Dilke, K. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.03.014 · Cited by 132 · see citing works
Loss of Matrix Adhesion Triggers Rapid Transformation-Selective Apoptosis in Fibroblasts
McGill, G. G., Shimamura, A., Bates, R. C., Savage, R. E., & Fisher, D. E. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.901 · Cited by 130 · see citing works
Colombi, M., Dordoni, C., Chiarelli, N., & Ritelli, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31429 · Cited by 127 · see citing works
Self-citationLiu, S., Shiwen, X., Kennedy, L., Pala, D., Chen, Y., Eastwood, M., Carter, D. E., Black, C. M., Abraham, D., & Leask, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1121 · Cited by 126 · see citing works
A Major Fraction of Fibronectin Present in the Extracellular Matrix of Tissues Is Plasma-derived
Moretti, F. A., Chauhan, A. K., Iaconcig, A., Porro, F., Baralle, F. E., & Muro, A. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611315200 · Cited by 120 · see citing works
Gu, J., Fujibayashi, A., Yamada, K. M., & Sekiguchi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200383200 · Cited by 118 · see citing works
Squamous Cell Carcinoma Cell Aggregates Escape Suspension-induced, p53-mediated Anoikis
Zhang, Y., Lü, H., Dazin, P. F., & Kapila, Y. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407953200 · Cited by 117 · see citing works
Zoppi, N., Gardella, R., De Paepe, A., Barlati, S., & Colombi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312609200 · Cited by 107 · see citing works
Self-citationIdentification and Characterization of a Novel Integrin-Linked Kinase Inhibitor
Lee, S.-L., Hsu, E., Chou, C.-C., Chuang, H.-C., Bai, L., Kulp, S. K., & Chen, C. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007744 · Cited by 107 · see citing works
Borkham-Kamphorst, E., Schaffrath, C., Van de Leur, E., Haas, U., Tihaa, L., Meurer, S. K., Nevzorova, Y. A., Liedtke, C., & Weiskirchen, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.023 · Cited by 105 · see citing works
Miller, R. E., Belmadani, A. A., Ishihara, S., Tran, P. B., Ren, D., Miller, R. J., & Malfait, A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39291 · Cited by 104 · see citing works
Wu, C., Hughes, P. E., Ginsberg, M. H., & McDonald, J. A. (1996) · Cell Communication & Adhesion · doi:10.3109/15419069609014219 · Cited by 103 · see citing works
Lee, S. W., Won, J. Y., Kim, W. J., Lee, J., Kim, K., Youn, S., Kim, J., Lee, E. J., Kim, Y.-J., Kim, K. W., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.146 · Cited by 102 · see citing works
Scaffidi, A. K., Petrovic, N., Moodley, Y. P., Fogel‐Petrovic, M., Kroeger, K. M., Seeber, R. M., Eidne, K. A., Thompson, P. J., & Knight, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403010200 · Cited by 101 · see citing works
He, T., Quan, T., Shao, Y., Voorhees, J. J., & Fisher, G. J. (2014) · AGE · doi:10.1007/s11357-014-9623-6 · Cited by 97 · see citing works
Fibronectin Beneath Reepithelializing Epidermis in Vivo: Sources and Significance
Clark, R. A. F., Winn, H. J., Dvorak, H. F., & Colvin, R. B. (1983) · Journal of Investigative Dermatology · doi:10.1038/jid.1983.7 · Cited by 90 · see citing works
(2017) · PubMed · Cited by 90 · see citing works
CCN2 Is Required for the TGF-β Induced Activation of Smad1 - Erk1/2 Signaling Network
Nakerakanti, S. S., Bujor, A. M., & Trojanowska, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021911 · Cited by 85 · see citing works
Kato, J., & Svensson, C. I. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.014 · Cited by 83 · see citing works
Chiarelli, N., Carini, G., Zoppi, N., Dordoni, C., Ritelli, M., Venturini, M., Castori, M., & Colombi, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161347 · Cited by 78 · see citing works
Self-citationYeh, Y.-Y., Chiao, C.-C., Kuo, W.-Y., Hsiao, Y., Chen, Y., Wei, Y., Lai, T.-H., Fong, Y., & Tang, C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.017 · Cited by 70 · see citing works
The role of fibronectins in embryonic cell migrations
Dufour, S., Duband, J., Kornblihtt, A. R., & Thiery, J. P. (1988) · Trends in Genetics · doi:10.1016/0168-9525(88)90076-5 · Cited by 69 · see citing works
Janecke, A. R., Li, B., Boehm, M., Krabichler, B., Rohrbach, M., Müller, T., Fuchs, I., Golas, G., Katagiri, Y., Ziegler, S. G., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37383 · Cited by 66 · see citing works
Self-citationThe Genetics of Soft Connective Tissue Disorders
Vanakker, O. M., Callewaert, B. L., Malfait, F., & Coucke, P. J. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050039 · Cited by 66 · see citing works
Regulation of membrane traffic by integrin signaling
Wickström, S. A., & Fässler, R. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.02.003 · Cited by 65 · see citing works
Integrin αvβ3 as a target in the prevention of neointimal hyperplasia
小久保, 拓., Uchida, H., & Choi, E. T. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.02.069 · Cited by 60 · see citing works
Integrin αvβ3 Signaling in Tumor-Induced Bone Disease
Kwakwa, K. A., & Sterling, J. A. R. (2017) · Cancers · doi:10.3390/cancers9070084 · Cited by 57 · see citing works
Tapia, J. A., Camello‐Almaraz, C., Jensen, R. T., & Garcı́a, L. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00157-8 · Cited by 56 · see citing works
Ishikawa, Y., & Bächinger, H. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561944 · Cited by 52 · see citing works
Focal Adhesion Kinase: A Key Mediator of Transforming Growth Factor Beta Signaling in Fibroblasts
Leask, A. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0363 · Cited by 51 · see citing works
Exclusion of candidate genes in a family with arterial tortuosity syndrome
Gardella, R., Zoppi, N., Assanelli, D., Muiesan, M. L., Barlati, S., & Colombi, M. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20589 · Cited by 50 · see citing works
Self-citationZoppi, N., Chiarelli, N., Cinquina, V., Ritelli, M., & Colombi, M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv382 · Cited by 50 · cited 14× · see citing works
“The exact pathomechanisms by which GLUT10 deficiency leads to the generalized ECM disarray, which reflects not only the typical ATS vascular anomalies but also the multisystem involvement overlapping with EDSs [171], were debated for long time and remain incompletely explored [98,99,105,115,116,172].”
BackgroundInfluentialSelf-citationZoppi, N., Chiarelli, N., Binetti, S., Ritelli, M., & Colombi, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.005 · Cited by 49 · see citing works
Self-citationMatrix mechanics and receptor–ligand interactions in cell adhesion
Harjanto, D., & Zaman, M. H. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b913064k · Cited by 47 · see citing works
Glucose transporter 10 and arterial tortuosity syndrome: The vitamin C connection
Segade, F. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.011 · Cited by 46 · see citing works
Chiarelli, N., Carini, G., Zoppi, N., Ritelli, M., & Colombi, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191220 · Cited by 45 · cited 1× · see citing works
“In vEDS cells, an ER perturbation was suggested by the abnormal ER distribution of the protein disulfide isomerase enzyme and by reduced expression of FKBP22, an ER resident peptidyl-prolyl cis-trans-ER isomerase involved in the folding of COLLIII triple helix [108,139,140].”
BackgroundSelf-citationCaspase-dependent cleavage of tensin induces disruption of actin cytoskeleton during apoptosis
Kook, S., Kim, D. H., Shim, S. R., Kim, W., Chun, J.-S., & Song, W. K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00280-8 · Cited by 44 · see citing works
Alternative Splicing of Chicken Fibronectin in Embryos and in Normal and Transformed Cells
Norton, P. A., & HYNES, R. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.12.4297-4307.1987 · Cited by 41 · see citing works
Ritelli, M., Chiarelli, N., Zoppi, N., Dordoni, C., Quinzani, S., Traversa, M., Venturini, M., Calzavara-Pinton, P., & Colombi, M. (2015) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.11.005 · Cited by 37 · see citing works
Self-citationThe role of the extracellular matrix in chronic pain following injury
Tajerian, M., & Clark, J. D. (2015) · Pain · doi:10.1097/01.j.pain.0000460323.80020.9d · Cited by 34 · see citing works
Endothelial integrins and their role in maintaining the integrity of the vessel wall
Dejana, E., Raiteri, M., Resnati, M., & Lampugnani, M. G. (1993) · Kidney International · doi:10.1038/ki.1993.11 · Cited by 33 · see citing works
FAK-independent αvβ3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts
Zoppi, N., Barlati, S., & Colombi, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.03.003 · Cited by 31 · see citing works
Self-citationSong, H. Y., Kim, M. Y., Kim, K. H., Lee, I. H., Shin, S., Lee, J. S., & Kim, J. H. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.8.057 · Cited by 30 · see citing works
Németh, C. E., Marcolongo, P., Gamberucci, A., Fulceri, R., Benedetti, A., Zoppi, N., Ritelli, M., Chiarelli, N., Colombi, M., Willaert, A., et al. (2016) · FEBS Letters · doi:10.1002/1873-3468.12204 · Cited by 30 · see citing works
Self-citationChen, S., Shiau, A., Li, Y., Lin, C., Jou, I., Liu, M.-F., Wu, C., & Wang, C. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38899 · Cited by 29 · see citing works
Laer, L. V., Proost, D., & Loeys, B. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1773-x · Cited by 28 · see citing works
Larroque-Cardoso, P., Mucher, E., Grazide, M.-H., Josse, G., Schmitt, A.-M., Nadal-Wollbold, F., Žarković, K., Salvayre, R., & Nègre‐Salvayre, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.015 · Cited by 28 · see citing works
Bruch’s membrane abnormalities in PRDM5-related brittle cornea syndrome
Porter, L. F., Gallego‐Pinazo, R., Keeling, C. L., Kamieniorz, M., Zoppi, N., Colombi, M., Giunta, C., Bonshek, R. E., Manson, F. D. C., & Black, G. C. M. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0360-4 · Cited by 28 · see citing works
Self-citationExtracellular Matrix: Pathobiology and Signaling
Gullberg, D., Paraskevi, H., Schaefer, L., Tenni, R., Theocharis, A. D., Winberg, J.-O., & Karamanos, N. K. (2012) · De Gruyter eBooks · doi:10.1515/9783110258776 · Cited by 27 · see citing works
Kajihara, I., Jinnin, M., Honda, N., Makino, K., Makino, T., Masuguchi, S., Sakai, K., Fukushima, S., Inoue, Y., & Ihn, H. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0698-6 · Cited by 26 · see citing works
A family of fibronectin mRNAs in human normal and transformed cells
Colombi, M., Barlati, S., Kornblihtt, A. R., Baralle, F. E., & Vaheri, A. I. (1986) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(86)90056-4 · Cited by 25 · see citing works
Self-citationRossier, O., & Giannone, G. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.11.004 · Cited by 23 · see citing works
Wójcik‐Pszczoła, K., Jakieła, B., Plutecka, H., Koczurkiewicz, P., Madeja, Z., Michalik, M., & Sanak, M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.09.002 · Cited by 22 · see citing works
Zoppi, N., Ritelli, M., & Colombi, M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.06.004 · Cited by 21 · see citing works
Self-citationKajihara, I., Jinnin, M., Honda, N., Makino, K., Makino, T., Masuguchi, S., Sakai, K., Fukushima, S., Inoue, Y., & Ihn, H. (2013) · Modern Rheumatology · doi:10.3109/s10165-012-0698-6 · Cited by 20 · see citing works
Gamberucci, A., Marcolongo, P., Németh, C. E., Zoppi, N., Szarka, A., Chiarelli, N., Hegedűs, T., Ritelli, M., Carini, G., Willaert, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081820 · Cited by 17 · see citing works
Self-citationRNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer Cells
Lu, M., Miao, Y., Qi, L., Bai, M., Zhang, J., & Feng, Y. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14549667333963 · Cited by 15 · see citing works
Colombi, M., Moro, L., Zoppi, N., Ghinelli, A., & Barlati, S. (1991) · Cell Biology International Reports · doi:10.1016/0309-1651(91)90091-v · Cited by 8 · see citing works
Self-citation4.3 Plasmin and the plasminogen activator system in health and disease
Svineng, G., Magnussen, S. N., & Hadler‐Olsen, E. (2012) · De Gruyter eBooks · doi:10.1515/9783110258776.261 · Cited by 8 · see citing works
Activated αvβ3 Integrin Targeting in Injury-Induced Vascular Remodeling
Sadeghi, M. M., & Bender, J. R. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.07.003 · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 185 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury
Yokota, T., McCourt, J. L., Ma, F., Ren, S. V., Li, S., Kim, T. P., Kurmangaliyev, Y. Z., Nasiri, R., Ahadian, S., Nguyen, T. L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.030 · Cited by 209 · see citing works
Chiarelli, N., Ritelli, M., Zoppi, N., & Colombi, M. (2019) · Genes · doi:10.3390/genes10080609 · Cited by 82 · see citing works
Self-citationRole of Vitronectin and Its Receptors in Neuronal Function and Neurodegenerative Diseases
Ruzha, Y., Ni, J., Quan, Z., Li, H., & Qing, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012387 · Cited by 56 · see citing works
Morlino, S., Micale, L., Ritelli, M., Rohrbach, M., Zoppi, N., Vandersteen, A., MacKay, S. B., Agolini, E., Cocciadiferro, D., Sasaki, E., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13683 · Cited by 55 · see citing works
Self-citationLi, J., Ritelli, M., Ma, C. S., Rao, G., Habib, T., Corvilain, E., Bougarn, S., Cypowyj, S., Grodecká, L., Lévy, R., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aax7965 · Cited by 52 · see citing works
Self-citationUpdates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome
Forghani, I. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2018.1113 · Cited by 35 · see citing works
Rymen, D., Ritelli, M., Zoppi, N., Cinquina, V., Giunta, C., Rohrbach, M., & Colombi, M. (2019) · Genes · doi:10.3390/genes10110843 · Cited by 29 · see citing works
Self-citationRodrigues-Díez, R. R., Tejera‐Muñoz, A., Esteban, V., Steffensen, L. B., Rodrigues‐Díez, R., Orejudo, M., Rayego‐Mateos, S., Falke, L. L., Cannata‐Ortiz, P., Ortíz, A., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18201 · Cited by 24 · see citing works
Chiarelli, N., Zoppi, N., Ritelli, M., Venturini, M., Capitanio, D., Gelfi, C., & Colombi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166051 · Cited by 27 · see citing works
Self-citationMalek, S., & Köster, D. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.649082 · Cited by 19 · see citing works
Cui, L., Zhao, Y., Zhong, Y., Zhang, L., Zhang, X., Guo, Z., Wang, F., Chen, X., Tong, H., & Fan, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.08.060 · Cited by 19 · see citing works
Management of shoulder instability in hypermobility-type Ehlers-Danlos syndrome
Broida, S. E., Sweeney, A. P., Gottschalk, M. B., & Wagner, E. R. (2021) · JSES Reviews Reports and Techniques · doi:10.1016/j.xrrt.2021.03.002 · Cited by 20 · see citing works
A quantitative review of nanotechnology‐based therapeutics for kidney diseases
Cheng, H., Ta, Y. N., Hsia, T., & Chen, Y. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1953 · Cited by 18 · see citing works
Ritelli, M., Chiarelli, N., Cinquina, V., Zoppi, N., Bertini, V., Venturini, M., & Colombi, M. (2022) · Cells · doi:10.3390/cells11244040 · Cited by 19 · see citing works
Self-citationChiarelli, N., Zoppi, N., Venturini, M., Capitanio, D., Gelfi, C., Ritelli, M., & Colombi, M. (2021) · Cells · doi:10.3390/cells10113236 · Cited by 18 · see citing works
Self-citationGulia, S., Chandra, P., & Das, A. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01179-4 · Cited by 16 · see citing works
Pathogenic mechanisms in genetically defined Ehlers–Danlos syndromes
Syx, D., & Malfait, F. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.06.001 · Cited by 14 · see citing works
Machol, K., Polak, U., Weisz‐Hubshman, M., Song, I.-W., Chen, S., Jiang, M., Chen, Y., Weis, M. A., Keene, D. R., Eyre, D. W., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab323 · Cited by 13 · see citing works
Role of peptide–cell surface interactions in cosmetic peptide application
He, B., Wang, F., & Qu, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1267765 · Cited by 15 · see citing works
Wang, T. J., Stecco, A., Hakim, A. J., & Schleip, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125587 · Cited by 14 · see citing works
Ju, Y., Shen, T., Guo, Z., Kong, Y., Huang, Y., & Hu, J. (2024) · Cell Biology International · doi:10.1002/cbin.12167 · Cited by 8 · see citing works
Modulating the extracellular matrix to treat wound healing defects in Ehlers-Danlos syndrome
Kelly‐Scumpia, K. M., Archang, M. M., Purbey, P. K., Yokota, T., Wu, R., McCourt, J. L., Li, S., Crosbie, R. H., Scumpia, P. O., & Deb, A. (2024) · iScience · doi:10.1016/j.isci.2024.110676 · Cited by 8 · see citing works
Ji, X., Han, T., Kang, N., Huang, S. M., & Liu, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118274 · Cited by 8 · see citing works
Hart, D. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031256 · Cited by 7 · see citing works
TAB2 c.1398dup variant leads to haploinsufficiency and impairs extracellular matrix homeostasis
Morlino, S., Carbone, A., Ritelli, M., Fusco, C., Giambra, V., Nardella, G., Notarangelo, A., Panelli, P., Mazzoccoli, G., Zoppi, N., et al. (2019) · Human Mutation · doi:10.1002/humu.23834 · Cited by 7 · see citing works
Self-citationChiarelli, N., Cinquina, V., Martini, P. G. V., Bertini, V., Zoppi, N., Venturini, M., Ritelli, M., & Colombi, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166915 · Cited by 7 · see citing works
Self-citationMethotrexate-Loaded Chitosan Oligosaccharide-ES2 for Targeted Cancer Therapy
Tang, W., Hou, H., Wang, H., Gao, X., Zhao, F., Di, Y., Sheng-li, J., Ling, P., Wang, F., Sun, F., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c06656 · Cited by 5 · see citing works
Chiarelli, N., Cinquina, V., Zoppi, N., Bertini, V., Maddaluno, M., Leonibus, C. D., Settembre, C., Venturini, M., Colombi, M., & Ritelli, M. (2024) · Biomedicines · doi:10.3390/biomedicines12122749 · Cited by 4 · see citing works
Self-citationCui, H., Hu, H., He, X., Cui, H., & Ni, Q. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114947 · Cited by 2 · see citing works
Vitronectin in health and disease: Mechanisms and therapeutic implications
Yao, Z., Huang, J., Liu, Y., & Li, L. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102055 · Cited by 1 · see citing works
Advances in Research of Integrin αvβ3 in Tu-mor Diagnosis and Treatment
韩, 田. (2019) · Pharmacy Information · doi:10.12677/pi.2019.83010
Dendrobates pumilio. Las ranas flecha venenosas de la Isla Bastimentos, Bocas del Toro (Panamá)
Fornelino, M. M., & Coll, M. (2001) · Reptilia: revista especializada en reptiles, anfibios y artrópodos
Paiba, N., & Harris, M. D. (2023) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2023.102231
Effects of SPARC and Possible Receptors on Colon Cancer Cell Line
Mısırlı, D., Özakpınar, Ö. B., Şekerler, T., Aru, B., Demirel, G. Y., Tunoğlu, S., & Özsavcı, D. (2023) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1100770
Cyclosporine A improves the binding of mouse embryos to fibronectin
Shengnan, T., Mei, Z., Jiaxing, W., Li, D., Ma, Y., & Huang, Y. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16046
Integrin Signaling Pathways in Aortic Aneurysm and Dissection
Chen, T., Li, P., 童竑章, Chen, M., & Lu, L. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45868
Олеговна, Н. Е., Фаритовна, М. Э., Сергеевич, К. В., & Afanasiev, S. A. (2026) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2026-15-4-6-21
- Authors
- Zoppi, N., Chiarelli, N., Ritelli, M., & Colombi, M.
- Affiliations
- University of Brescia (IT)
- Corresponding author
- Colombi, Marina
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-26
- Volume
- 19
- Issue
- 4
- Pages
- 982
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979373
- OpenAlex
- W2791421919
- Cited by
- 37
- References
- 185
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 7 · 2023: 6 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 1
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- integrin αvβ3, Ehlers-Danlos syndrome, arterial tortuosity syndrome, dermal fibroblasts, fibronectin, extracellular matrix remodeling, anoikis, p60src, EGF receptor, p125FAK, myofibroblast differentiation, GLUT10, dehydroascorbic acid, redox imbalance, hypermobility spectrum disorders, connective tissue diseases
- MeSH terms
- Arteries, Ehlers-Danlos Syndrome, Humans, Joint Instability, Skin Diseases, Genetic, Signal Transduction, Collagen Type III, Collagen Type V, Integrin alphaVbeta3, Vascular Malformations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review